BioSpace News Archive

Pharming Group to participate in June 2024 investor conferences

Leiden, the Netherlands, June 3, 2024: Pharming Group N.V. announces that Pharming’s management will participate in the following investor conferences in the month of June:.

June 3, 2024
·
1 min read
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improve gastrointestinal care

QIAGEN announced the launch of the QIAstat-Dx Gastrointestinal Panel 2 in the United States.

June 3, 2024
·
8 min read
Job Trends

Thermo Fisher Scientific Opens New GMP-certified Ultra-cold Facility in the EU to Accelerate Advanced Therapies Development

Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced therapies.

June 3, 2024
·
3 min read
Germans Trias i Pujol Hospital in Spain Launches Telehealth and Remote Patient Management Program Using Masimo W1® Medical Watches and Radius VSM™ Wearable Continuous Vital Signs Monitors

Masimo announced that Germans Trias i Pujol, a pioneering hospital serving more than 800,000 people in north Barcelona, Spain, is launching a breakthrough telehealth and remote patient management initiative using Masimo technology.

June 3, 2024
·
11 min read
Drug Development

Alligator Bioscience’s Phase 2 mitazalimab Pancreatic Cancer Data Published in The Lancet Oncology

Alligator Bioscience announced the publication of positive Phase 2 data on its lead drug candidate mitazalimab in first line metastatic pancreatic cancer in The Lancet Oncology.

June 3, 2024
·
5 min read
Business

Orion is developing the Finnish life science industry in a unique collaboration project

Orion is participating in a project led by the University of Turku for which Business Finland recently granted 11.7M€ funding.

June 3, 2024
·
4 min read
Trinity Biotech Launches its Continuous Glucose Monitoring Microsite to Showcase its Innovative & Differentiated Technology

Trinity Biotech plc a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced the launch of its continuous glucose monitoring microsite.

June 3, 2024
·
4 min read
Business

PhoreMost Achieves Second Milestone in Target Discovery Alliance with Boehringer Ingelheim

PhoreMost Ltd., has triggered a second milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim.

June 3, 2024
·
2 min read
Genetown

QurAlis Grants Lilly Exclusive Global License for QRL-204, a Potentially First-in-Class Precision Therapy That Restores UNC13A Function in ALS and FTD

QurAlis Corporation announced that it has entered into an exclusive license agreement with Eli Lilly and Company in which QurAlis is granting Lilly global rights to develop and commercialize QRL-204, a potentially best-in-class splice-switching antisense oligonucleotide designed to restore UNC13A function in amyotrophic lateral sclerosis, frontotemporal dementia, and other neurodegenerative diseases.

June 3, 2024
·
4 min read
BioCapital

NeoImmuneTech’s New Data at ASCO 2024 Highlights Enhanced Benefits of Combining NT-I7 with Checkpoint Inhibitors (CPI) in Immuno-Oncology

NeoImmuneTech, Inc., a T cell-focused therapeutics company, announced promising interim results of its major clinical trial NIT-110 of NT-I7, at the 2024 American Society of Clinical Oncology global meeting held in Chicago, from May 31 to June 4.

June 3, 2024
·
6 min read